These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8786998)

  • 21. Identification and insertion of 3-carbon bridges in protein disulfide bonds: a computational approach.
    Zloh M; Shaunak S; Balan S; Brocchini S
    Nat Protoc; 2007; 2(5):1070-83. PubMed ID: 17545999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refolding of potato carboxypeptidase inhibitor by molecular dynamics simulations with disulfide bond constraints.
    Martí-Renom MA; Stote RH; Querol E; Avilés FX; Karplus M
    J Mol Biol; 1998 Nov; 284(1):145-72. PubMed ID: 9811548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional structure of recombinant human interferon-gamma.
    Ealick SE; Cook WJ; Vijay-Kumar S; Carson M; Nagabhushan TL; Trotta PP; Bugg CE
    Science; 1991 May; 252(5006):698-702. PubMed ID: 1902591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural analysis of a biologically active echistatin analogue des(46-49)-[Ala8,37]-echistatin gamma with three disulfide bonds by 2D-NMR and computer graphics.
    Chuang LC; Chen PY; Chen C; Huang TH; Wang KT; Chiou SH; Wu SH
    Biochem Biophys Res Commun; 1996 Mar; 220(2):246-54. PubMed ID: 8645291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A stable disulfide-free gene-3-protein of phage fd generated by in vitro evolution.
    Kather I; Bippes CA; Schmid FX
    J Mol Biol; 2005 Dec; 354(3):666-78. PubMed ID: 16259997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).
    Runkel L; Meier W; Pepinsky RB; Karpusas M; Whitty A; Kimball K; Brickelmaier M; Muldowney C; Jones W; Goelz SE
    Pharm Res; 1998 Apr; 15(4):641-9. PubMed ID: 9587963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of recombinant human interleukin-22.
    Nagem RA; Colau D; Dumoutier L; Renauld JC; Ogata C; Polikarpov I
    Structure; 2002 Aug; 10(8):1051-62. PubMed ID: 12176383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of disulfide bonds in wheat gluten proteins by means of mass spectrometry/electron transfer dissociation.
    Lutz E; Wieser H; Koehler P
    J Agric Food Chem; 2012 Apr; 60(14):3708-16. PubMed ID: 22439977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfide by Design: a computational method for the rational design of disulfide bonds in proteins.
    Dombkowski AA
    Bioinformatics; 2003 Sep; 19(14):1852-3. PubMed ID: 14512360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A point mutation that decreases the thermal stability of human interferon gamma.
    Lunn CA; Fossetta J; Murgolo N; Zavodny PJ; Lundell D; Narula SK
    Protein Eng; 1992 Apr; 5(3):249-52. PubMed ID: 1409545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipase A2 engineering. The roles of disulfide bonds in structure, conformational stability, and catalytic function.
    Zhu H; Dupureur CM; Zhang X; Tsai MD
    Biochemistry; 1995 Nov; 34(46):15307-14. PubMed ID: 7578147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity.
    Lortat-Jacob H; Grimaud JA
    Cell Mol Biol; 1991; 37(3):253-60. PubMed ID: 1934005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.
    Narhi LO; Hua QX; Arakawa T; Fox GM; Tsai L; Rosenfeld R; Holst P; Miller JA; Weiss MA
    Biochemistry; 1993 May; 32(19):5214-21. PubMed ID: 8494898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
    Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
    J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of disulfide bonds in recombinant human interleukin 6 conformation.
    Rock FL; Li X; Chong P; Ida N; Klein M
    Biochemistry; 1994 May; 33(17):5146-54. PubMed ID: 8172889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of interferon-gamma antagonists as an example of biotechnology application to approach new immunomodulators.
    Garotta G; Ozmen L; Fountoulakis M
    Pharmacol Res; 1989; 21 Suppl 2():5-17. PubMed ID: 2534322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A.
    Laity JH; Lester CC; Shimotakahara S; Zimmerman DE; Montelione GT; Scheraga HA
    Biochemistry; 1997 Oct; 36(42):12683-99. PubMed ID: 9335525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topology of receptor binding domains of mouse IFN-gamma.
    Jarpe MA; Johnson HM
    J Immunol; 1990 Nov; 145(10):3304-9. PubMed ID: 1700005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of interleukin 10 reveals an interferon gamma-like fold.
    Walter MR; Nagabhushan TL
    Biochemistry; 1995 Sep; 34(38):12118-25. PubMed ID: 7547951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.